The HealthTech and Medical Device industries have entered one of their most transformative periods in the last decade. Consolidation is accelerating across nearly every category—from AI-powered diagnostics and robotic surgery to neuromodulation and remote patient monitoring. As investors pour into digitally enabled care and major strategic buyers race to acquire breakthrough technologies, the landscape is shifting in ways that will permanently redefine competitive advantage.
These M&A waves are not simply about acquiring technologies; they are fundamentally altering CEO succession, executive search priorities, and board recruiting strategies across
